Chicago Atlantic BDC (NASDAQ:LIEN) Issues Earnings Results

Chicago Atlantic BDC (NASDAQ:LIEN) released its earnings results on Thursday. The company reported $0.42 EPS for the quarter, beating the consensus estimate of $0.35 by $0.07, Zacks reports. Chicago Atlantic BDC had a return on equity of 3.25% and a net margin of 21.50%.

Chicago Atlantic BDC Trading Up 2.4%

Chicago Atlantic BDC stock traded up $0.24 during mid-day trading on Thursday, hitting $10.28. The stock had a trading volume of 8,961 shares, compared to its average volume of 30,148. The stock has a market capitalization of $234.59 million, a PE ratio of 27.78 and a beta of 0.27. Chicago Atlantic BDC has a 12 month low of $9.70 and a 12 month high of $13.24. The stock has a 50-day simple moving average of $10.50 and a two-hundred day simple moving average of $10.41.

Analysts Set New Price Targets

Separately, Zacks Research raised shares of Chicago Atlantic BDC to a “hold” rating in a research note on Wednesday, August 20th. Three investment analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company has an average rating of “Hold”.

Hedge Funds Weigh In On Chicago Atlantic BDC

Large investors have recently modified their holdings of the stock. Corient Private Wealth LLC bought a new stake in shares of Chicago Atlantic BDC in the second quarter valued at about $2,784,000. Northeast Financial Consultants Inc bought a new stake in shares of Chicago Atlantic BDC during the 2nd quarter valued at approximately $851,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in shares of Chicago Atlantic BDC in the 2nd quarter valued at $619,000. XTX Topco Ltd acquired a new stake in shares of Chicago Atlantic BDC during the second quarter valued at about $112,000. Finally, Westwood Holdings Group Inc. bought a new stake in Chicago Atlantic BDC during the 2nd quarter worth approximately $111,000. 4.36% of the stock is owned by institutional investors.

Chicago Atlantic BDC Company Profile

Chicago Atlantic BDC Inc is a specialty finance company which has elected to be regulated as a business development company. Its investment objective is to maximize risk-adjusted returns on equity for its stockholders by investing primarily in direct loans to privately held middle-market companies, with a primary focus on cannabis companies.